Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO Price-to-Tangible-Book is 0.79 as of Sep. 21, 2026. The stock has 1 warning sign investors should review. Among 151 Medical Diagnostics & Research companies, Invitro International ranks better than 90.73% on this metric.
The historical rank and industry rank for Invitro International's Price-to-Tangible-Book or its related term are showing as below:
IVRO'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.75 Med: 1.15 Max: 1.45
Current: 0.75
During the past 11 years, Invitro International's highest Price to Tangible Book Ratio was 1.45. The lowest was 0.75. And the median was 1.15.
IVRO's Price-to-Tangible-Book is ranked better than 90.73% of 151
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.61
vs IVRO: 0.75
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Invitro International Price-to-Tangible-Book Related Terms
Invitro International Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Invitro International's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International Price-to-Tangible-Book Chart
IVRO vs IDTA, FUNI, BIAF: Price-to-Tangible-Book Comparison
For the Diagnostics & Research subindustry, Invitro International's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Price-to-Tangible-Book vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Invitro International's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Invitro International (IVRO) has a Price-to-Tangible-Book of 0.79 as of Sep. 21, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #14 out of 151 companies in the Medical Diagnostics & Research industry, placing it in the top 9.3%.
Is Invitro International's Price-to-Tangible-Book too high?
Invitro International's current Price-to-Tangible-Book is 0.79. The Medical Diagnostics & Research industry median Price-to-Tangible-Book is 2.61. Invitro International's value of 0.79 is 69.7% below this industry median. Based on the distribution chart, Invitro International ranks #14 out of 151 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Price-to-Tangible-Book compare to IDTA and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #14 out of 151 companies for Price-to-Tangible-Book. This places Invitro International in the top 9% of its industry — outperforming the majority of peers. The industry median Price-to-Tangible-Book is 2.61. Invitro International's value of 0.79 is 69.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Diagnostics & Research company?
The median Price-to-Tangible-Book among Medical Diagnostics & Research companies is 2.61, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invitro International's current Price-to-Tangible-Book of 0.79 is 69.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Invitro International and its competitors. For the Medical Diagnostics & Research industry, the median Price-to-Tangible-Book is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Price-to-Tangible-Book is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Fairly Valued. The stock's GF Value™ is $0.06, compared to a current price of $0.06 — trading right at its estimated fair value. The current Price-to-Tangible-Book is 0.79 and 69.7% below the Medical Diagnostics & Research industry median of 2.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Invitro International (IVRO), the current Price-to-Tangible-Book is 0.79 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
